Ratings Just Issued on these 4 Healthtech Tickers

Tickers Inside If you cannot see this email properly, please click [here]( Dear Reader, Below is a list of 4 Buy Ratings made by some of the Top Analysts on Wall Street for stocks in the HealthTech Sector...Keep in mind, we are not recommending these companies, just reporting what Wall Street Analysts have issued. [For all the latest analyst ratings in the HealthTech Sector, click here](. --------------------------------------------------------------- Sponsorship [More "Safe" Gold is Needed to Meet Growing Demand]( [See why American gold should be on every investor's radar.]( --------------------------------------------------------------- [CVRx, CVRX]( Frank Takkinen analyst at Lake Street reiterates coverage on [CVRx (CVRX)](in the Healthcare sector with a Buy rating. TipRanks.com has Takkinen rated as a 4.1 star analyst with a 40% return on investment and a 9.6% success rate. Takkinen has set a price target of $35. [TipRanks.com]( reports that [CVRx](currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $34.00. In addition, TradingView issued a Sell rating for [CVRX]( over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bearish short-term outlook. [Get the full story on other analysts covering CVRX by clicking here.]( --------------------------------------------------------------- [Sarepta Therapeutics, SRPT]( Hartaj Singh analyst at Oppenheimer reiterates coverage on [Sarepta Therapeutics (SRPT)](in the Healthcare sector with a Hold rating. TipRanks.com has Singh rated as a 4.8 star analyst with a 47% return on investment and a 14.5% success rate. Singh has set a price target of n/a. [TipRanks.com]( reports that [Sarepta Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $178.33. In addition, TradingView issued a buy rating for [SRPT]( over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bearish short-term outlook. [Get the full story on other analysts covering SRPT by clicking here.]( --------------------------------------------------------------- Sponsorship [Melting Glaciers Could Uncover Once-Hidden Minerals]( glaciers are a serious worry for climate scientists. But for miners exploring the "frozen north's" Golden Triangle, melting glaciers could help locate and extract both base and precious metals that were previously untouchable. [See how a changing climate could open up new resource investing opportunities.]( --------------------------------------------------------------- [Kura Oncology, KURA]( George Farmer analyst at Scotiabank reiterates coverage on [Kura Oncology (KURA)](in the Healthcare sector with a Hold rating. [TipRanks.com]( has Farmer rated as a 4.8 star analyst with a 70% return on investment and a 29% success rate. Farmer has set a price target of $22. [TipRanks.com]( reports that [Kura Oncology](currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $30.00. In addition, TradingView issued a buy rating for [KURA]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [Get the full story on other analysts covering KURA by clicking here.]( --------------------------------------------------------------- [Akebia Therapeutics, AKBA]( Ed Arce analyst at H.C. Wainwright reiterates coverage on [Akebia Therapeutics (AKBA)](in the Healthcare sector with a Buy rating. [TipRanks.com]( has Arce rated as a 4.6 star analyst with a 43% return on investment and a 9.3% success rate. Arce has set a price target of $5. [TipRanks.com]( reports that [Akebia Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $4.33. In addition, TradingView issued a buy rating for [AKBA]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bearish short-term outlook. [Get the full story on other analysts covering AKBA by clicking here.]( --------------------------------------------------------------- Sponsorship [Billionaires Race to Invest in AI Energy Breakthrough]( Jeff Bezos and Bill Gates are investing in AI energy. This AI-created energy is being hailed as the most exciting human discovery since fire. [Here’s how to invest alongside them.]( --------------------------------------------------------------- Just a reminder, one resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [Click here for more on Tipranks.com.]( Another great tool for charting is [TradingView.com](, and for more news [Google Finance](, so you might want to check that out too. To you financial future! The Editor --------------------------------------------------------------- Sponsorship ["America's Icebox" to Help Solve Gold Supply Crisis?]( and Russia are the largest global gold producers. American reliance on imported minerals is at record levels, leaving us vulnerable to foreign suppliers cutting off shipments for geopolitical reasons. Experts are calling for more U.S. mining to build safe and reliable supply chains for precious and base metals. [See how investors could benefit from new Alaskan mining projects.]( --------------------------------------------------------------- HealthTechMovers.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software